Half-year report · Q2
2503.TEDINET S100WHH8
Period2025-01-01 → 2025-06-30
Filed2025-08-08
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.14T | 2025-01-01 → 2025-06-30 | Cons. | Revenue IFRS |
| Revenue | ¥2.34T | 2024-01-01 → 2024-12-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥1.10T | 2024-01-01 → 2024-06-30 | Cons. | Revenue IFRS |
| Operating income | ¥68.7bn | 2025-01-01 → 2025-06-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥80.9bn | 2024-01-01 → 2024-06-30 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥83.8bn | 2025-01-01 → 2025-06-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥139.7bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥108.5bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥52.8bn | 2025-01-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥58.2bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥57.2bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥60.5bn | 2025-01-01 → 2025-06-30 | Cons. | Profit loss IFRS |
| Net income | ¥74.2bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss IFRS |
| Total assets | ¥3.30T | at 2025-06-30 | Cons. | Assets IFRS |
| Total assets | ¥3.35T | at 2024-12-31 | Cons. | Assets IFRS |
| Total assets | ¥3.13T | at 2024-06-30 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥1.89T | at 2025-06-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥1.82T | at 2024-12-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥1.41T | at 2025-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.53T | at 2024-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.59T | at 2024-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.43T | at 2023-12-31v | Cons. | Equity IFRS |
| Equity (owners) | ¥1.12T | at 2025-06-30 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥1.18T | at 2024-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥1.29T | at 2024-06-30 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥132.4bn | at 2025-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥118.6bn | at 2024-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥138.4bn | at 2024-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥131.4bn | at 2023-12-31v | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥67.3bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥242.8bn | 2024-01-01 → 2024-12-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥108.7bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥61.6bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥329.4bn | 2024-01-01 → 2024-12-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥116.0bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | ¥35.8bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | ¥58.1bn | 2024-01-01 → 2024-12-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥21.6bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥65.23 | 2025-01-01 → 2025-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥71.87 | 2024-01-01 → 2024-12-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥70.65 | 2024-01-01 → 2024-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥65.22 | 2025-01-01 → 2025-06-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥71.86 | 2024-01-01 → 2024-12-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥70.65 | 2024-01-01 → 2024-06-30 | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 34.0% | at 2025-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 35.2% | at 2024-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 41.2% | at 2024-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 46
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2025-01-01 → 2025-06-30 | ¥47.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2025-01-01 → 2025-06-30 | ¥14.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥32.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2025-01-01 → 2025-06-30 | −¥591m |
| Reconciling Itemsreconciling | revenue | 2025-01-01 → 2025-06-30 | −¥38.3bn |
| Reconciling Itemsreconciling | revenue intersegment | 2025-01-01 → 2025-06-30 | −¥38.3bn |
| Reconciling Itemsreconciling | segment profit | 2025-01-01 → 2025-06-30 | −¥30.0bn |
| jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥493.8bn |
| jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥492.6bn |
| jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segment | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥1.2bn |
| jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥53.2bn |
| jpcrp040300-q2r_E00395-000Health Sciencereportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥129.7bn |
| jpcrp040300-q2r_E00395-000Health Sciencereportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥127.2bn |
| jpcrp040300-q2r_E00395-000Health Sciencereportable segment | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥2.5bn |
| jpcrp040300-q2r_E00395-000Health Sciencereportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥8.6bn |
| jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥273.4bn |
| jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥271.8bn |
| jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segment | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥1.6bn |
| jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥29.5bn |
| jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥230.7bn |
| jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥230.5bn |
| jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segment | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥156m |
| jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥33.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-01-01 → 2024-06-30 | ¥45.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-01-01 → 2024-06-30 | ¥10.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥34.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-01-01 → 2024-06-30 | −¥331m |
| Reconciling Itemsreconciling | revenue | 2024-01-01 → 2024-06-30 | −¥38.5bn |
| Reconciling Itemsreconciling | revenue intersegment | 2024-01-01 → 2024-06-30 | −¥38.5bn |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-06-30 | −¥26.5bn |
| jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥513.7bn |
| jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥512.5bn |
| jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segment | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥1.2bn |
| jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥50.3bn |
| jpcrp040300-q2r_E00395-000Health Sciencereportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥71.1bn |
| jpcrp040300-q2r_E00395-000Health Sciencereportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥69.6bn |
| jpcrp040300-q2r_E00395-000Health Sciencereportable segment | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥1.6bn |
| jpcrp040300-q2r_E00395-000Health Sciencereportable segment | segment profit | 2024-01-01 → 2024-06-30 | −¥1.6bn |
| jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥271.5bn |
| jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥270.0bn |
| jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segment | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥1.5bn |
| jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥30.1bn |
| jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥233.0bn |
| jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥232.8bn |
| jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segment | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥132m |
| jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥41.1bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 858
| Item | Context | Value | Unit |
|---|---|---|---|
| Other non current assets nca IFRS | CurrentQuarterInstant | 48646000000 | JPY |
| Deferred tax assets IFRS | Prior1YearInstant | 109761000000 | JPY |
| Deferred tax assets IFRS | CurrentQuarterInstant | 98675000000 | JPY |
| Non current assets IFRS | Prior1YearInstant | 2312966000000 | JPY |
| Non current assets IFRS | CurrentQuarterInstant | 2289392000000 | JPY |
| Inventories ca IFRS | Prior1YearInstant | 358985000000 | JPY |
| Inventories ca IFRS | CurrentQuarterInstant | 355505000000 | JPY |
| Trade and other receivables ca IFRS | Prior1YearInstant | 502880000000 | JPY |
| Trade and other receivables ca IFRS | CurrentQuarterInstant | 432598000000 | JPY |
| Other financial assets ca IFRS | Prior1YearInstant | 8570000000 | JPY |
| Other financial assets ca IFRS | CurrentQuarterInstant | 10922000000 | JPY |
| Other current assets ca IFRS | Prior1YearInstant | 52142000000 | JPY |
| Other current assets ca IFRS | CurrentQuarterInstant | 48322000000 | JPY |
| Cash and cash equivalents IFRS | Prior1YearInstant | 118617000000 | JPY |
| Cash and cash equivalents IFRS | CurrentQuarterInstant | 132408000000 | JPY |
| Current assets other than assets held for sale ca IFRS | Prior1YearInstant | 1041193000000 | JPY |
| Current assets other than assets held for sale ca IFRS | CurrentQuarterInstant | 979754000000 | JPY |
| Assets held for sale IFRS | Prior1YearInstant | - | JPY |
| Assets held for sale IFRS | CurrentQuarterInstant | 32154000000 | JPY |
| Current assets IFRS | Prior1YearInstant | 1041193000000 | JPY |
| Current assets IFRS | CurrentQuarterInstant | 1011908000000 | JPY |
| Assets IFRS | Prior1YearInstant | 3354159000000 | JPY |
| Assets IFRS | CurrentQuarterInstant | 3301300000000 | JPY |
| Share capital IFRS | Prior1YearInstant | 102046000000 | JPY |
| Share capital IFRS | CurrentQuarterInstant | 102046000000 | JPY |
| Capital surplus IFRS | Prior1YearInstant | 9497000000 | JPY |
| Capital surplus IFRS | CurrentQuarterInstant | - | JPY |
| Retained earnings IFRS | Prior1YearInstant | 1130931000000 | JPY |
| Retained earnings IFRS | CurrentQuarterInstant | 1133761000000 | JPY |
| Treasury shares IFRS | Prior1YearInstant | -251376000000 | JPY |
| Treasury shares IFRS | CurrentQuarterInstant | -250993000000 | JPY |
| Other components of equity IFRS | Prior1YearInstant | 190427000000 | JPY |
| Other components of equity IFRS | CurrentQuarterInstant | 136906000000 | JPY |
| Equity attributable to owners of parent IFRS | Prior1YearInstant | 1181525000000 | JPY |
| Equity attributable to owners of parent IFRS | CurrentQuarterInstant | 1121720000000 | JPY |
| Non controlling interests IFRS | Prior1YearInstant | 352189000000 | JPY |
| Non controlling interests IFRS | CurrentQuarterInstant | 285535000000 | JPY |
| Equity IFRS | Prior1YearInstant | 1533714000000 | JPY |
| Equity IFRS | CurrentQuarterInstant | 1407255000000 | JPY |
| Bonds and borrowings ncl IFRS | Prior1YearInstant | 779583000000 | JPY |
| Bonds and borrowings ncl IFRS | CurrentQuarterInstant | 814374000000 | JPY |
| Other financial liabilities ncl IFRS | Prior1YearInstant | 87398000000 | JPY |
| Other financial liabilities ncl IFRS | CurrentQuarterInstant | 78922000000 | JPY |
| Retirement benefit liability ncl IFRS | Prior1YearInstant | 54986000000 | JPY |
| Retirement benefit liability ncl IFRS | CurrentQuarterInstant | 54069000000 | JPY |
| Provisions ncl IFRS | Prior1YearInstant | 7100000000 | JPY |
| Provisions ncl IFRS | CurrentQuarterInstant | 9126000000 | JPY |
| Liabilities from application of equity method ncl IFRS | Prior1YearInstant | 10458000000 | JPY |
| Liabilities from application of equity method ncl IFRS | CurrentQuarterInstant | 8970000000 | JPY |
| Other non current liabilities ncl IFRS | Prior1YearInstant | 13622000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |